Effects of Cannabidiol on Learning and Anxiety in College Students
Cannabidiol Effects on Learning and Anxiety
This study tests if a single dose of CBD can help college students with social anxiety feel less fear after a scary exercise.
Quick facts
| Phase | Early Phase 1 |
|---|---|
| Study type | Interventional |
| Enrollment | 160 (estimated) |
| Ages | 18 Years to 50 Years |
| Sex | All |
| Sponsor | University of Connecticut Academic / other |
| Locations | 1 site (Storrs, Connecticut) |
| Trial ID | NCT05283382 on ClinicalTrials.gov |
What this trial studies
This study investigates how Cannabidiol (CBD) may improve the extinction of fear responses in college students with elevated social anxiety. Participants will undergo a fear conditioning exercise where they learn to associate a face with a mild shock. Following this, half of the participants will receive a single dose of 600 mg CBD, while the other half will receive a placebo. The study will measure the effectiveness of CBD in reducing fear responses through physiological and subjective assessments.
Who should consider this trial
Good fit: Ideal candidates for this study are college students aged 18-50 who exhibit elevated levels of social anxiety.
Not a fit: Patients with heart problems, neurological disorders, or those currently using CBD or cannabis products may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a novel treatment option for individuals with social anxiety by enhancing their ability to overcome fear responses.
How similar studies have performed: While there is emerging research on CBD's effects on anxiety, this specific approach to fear conditioning extinction is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18-50 years of age Exclusion Criteria: 1. Difficulties seeing a computer screen 2. Anyone currently taking CBD within the last 24 hours. 3. Anyone using any cannabis product within the last 24 hours. 4. Heart problems or heart disease 5. A neurological disorder such as epilepsy, stroke, multiple sclerosis, tumor, vascular malformations, aneurysm 6. Are currently pregnant or breast-feeding
Where this trial is running
Storrs, Connecticut
- University of Connecticut — Storrs, Connecticut, United States (Recruiting)
Study contacts
- Study coordinator: Robert Astur, PhD
- Email: robert.astur@uconn.edu
- Phone: 2032369938
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.